Yalcin, S. Et Al. 2011. Bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trial. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15 .

Yalcin, S., Uslu, R., Dane, F., Yilmaz, U., Zengin, N., Buyukunal, E., ... Buyukberber, S.(2011). Bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trial. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.

Yalcin, ŞUAYİB Et Al. "Bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trial," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011

Yalcin, ŞUAYİB Et Al. "Bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trial." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011

Yalcin, S. Et Al. (2011) . "Bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trial." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.

@article{article, author={ŞUAYİB YALÇIN Et Al. }, title={Bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trial}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2011}